News
PTC Therapeutics announces European Commission marketing authorization for Upstaza
Lyme Disease Awareness Month: A Spotlight on TBRD funded Lyme Disease Initiatives
Gates Foundation awards MassBiologics $2M to develop treatment for enteric diarrhea.
Serum Institute of India launches Rabishield, in partership with MassBiologics.
Serum Institute of India unveils new rabies treatment.
Rabies treatment developed at MassBiologics is launched in India.
MassBiologics develops rabies treatment with Indian manufacturer.
MassBiologics treatment for Lyme Disease on WBZ TV news.
MassBiologics continues to pursue unmet medical needs.
Doctors see gains against 'an Urgent Threat,' C.Diff
MassBiologics developing promising alternative treatment for diphtheria.
MassBiologics Discovery granted FDA approval.
MassBiologics Discovery for Lyme Disease PrEP.
Researchers isolate Ebola antibodies in quest for vaccine, treatment.
MassBiologics discovery is nearing launch in India.
Local Delegation tours MassBiologics SouthCoast Facility.
MassBiologics collaborator AbCellera Announces their Success.
Grifols Obtains Exclusive Rights to Market and Distribute MassBiologics' Td Vaccine in US.
MassBiologics now fully manufacturing vaccine at Mattapan facility.
Gene therapy startup Voyager announces manufacturing partnership with MassBiologics
MassBiologics scientist publishes guide to large scale mammalian cell culture equipment
MassBiologics CEO, Mark Klempner discusses Lyme disease
Merck study reveals mechanism of action for anti-C.difficile MAb developed at MassBiologics